Proteochemometric modeling strengthens the role of Q299 for GABA transporter subtype selectivity
Kickinger, S.; Seiler, A.; Digles, D.; Ecker, G. F.
Show abstract
Proteochemometric modeling (PCM) combines ligand information as well as target information in order to predict an output variable of interest (e.g. activity of a compound). The big advantage of PCM compared to conventional Quantitative Structure-Activity Relationship (QSAR) modeling is, that by creating a single model one can not only predict the affinity of a diverse set of compounds to a diverse set of targets, but also extrapolate the specific ligand-protein interactions that might be relevant for activity. In this study, we compiled a dataset of 323 compounds and their bioactivity data regarding the inhibition of the four GABA-transporter (GAT1/BGT1/GAT2/GAT3) subtypes, which are potential new drug targets for treating epilepsy. Proteochemometric modeling using partial least squares and random forest provided models which performed equally well than conventional QSAR models for each individual transporter. However, by analyzing the importance of the protein descriptors used in the PCM models, we identified the amino acid Leu300/Q299/L294/L314/ in GAT1/BGT1/GAT2/GAT3 to be relevant for binding and subtype selectivity.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19 94%
- A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2 94%
- Identification of novel chemical scaffolds that inhibit the growth of Mycobacterium tuberculosis in macrophages 92%
Similar papers in this journal
- Discovery of Z1362873773: A Novel Fascin Inhibitor from a Large Chemical Library for Colorectal Cancer 95%
- HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2 94%
- Bacopa monnieri phytochemicals as promising BACE1 inhibitors for Alzheimers Disease Therapy 94%
Similar papers in this journal
- The use of a graph database is a complementary approach to a classical similarity search for identifying commercially available fragment merges 95%
- Predicting antimicrobial class specificity of small molecules using machine learning 95%
- Benchmarking of Small Molecule Feature Representations for hERG, Nav1.5, and Cav1.2 Cardiotoxicity Prediction 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.